-
Sunken Silk Road city reveals Central Asia's lost history
-
EU, China to hold Beijing talks to avert trade war
-
Three years on, Israeli rescuer cannot escape October 7
-
Bolsonaro edges past Lula as nail-biter Brazil vote goes to a run-off
-
Research into weight-loss drugs tipped for Nobel as award week opens
-
Rubio visits Iceland as US boosts Arctic presence
-
US Supreme Court hears bid to shut the door on climate suits
-
Bolsonaro leads Lula as nail-biter Brazil vote goes to a run-off
-
Chourio walk-off single lifts Brewers over Padres
-
Patriots inflict first Bills defeat as Chiefs keep winning
-
Flavio Bolsonaro leads Lula in near-done Brazil vote count
-
Pacific nations take centre stage at 'pre-COP' climate summit
-
Flavio Bolsonaro leads Lula in partial Brazil poll results
-
Ronaldo can return to Portugal team if he wants: coach Jesus
-
Titan FX Launches Second “Dream Beyond Borders 2.0” Brand Commercial Featuring Keisuke Honda
-
Portugal move into Nations League knockout stage, Germany held
-
Patriots inflict first Bills defeat as Rams surge late
-
Ronaldo-less Portugal beat Norway to reach Nations League quarters
-
Brazil's Indigenous back Lula as El Nino fuels forest fires
-
Bosnian Serb strongman claims election win, thanks Trump and Putin
-
Brazil braces for results of election battle between Lula and Bolsonaro
-
Israel wear black armbands in Ireland tie over Hamas attack
-
Indians protest election chief ahead of top court hearing
-
'I fear it could drag on': anxiety takes hold in Ethiopian city wrested from rebels
-
'Verity' kills, Cruise bombs in N. American movie theaters
-
Brazil's Lula and Flavio Bolsonaro face off in knife-edge election
-
Colts top Commanders in NFL London game
-
UK Green party adopts 'Zionism is racism' policy
-
Hundreds of schools to shut Monday as student protests rock France
-
Rio favela residents vote with little hope
-
Three previous two-time Arc de Triomphe winners
-
Evenepoel puts worlds 'disappointment' to bed with European crown
-
'Champion' Daryz wins second successive Arc in fine style
-
Two-time winning Arc trainer Rouget bows out in emotional farewell
-
Daryz wins second successive Prix de l'Arc de Triomphe
-
Battling Djokovic stuns top seed Zverev at China Open
-
England's seven-goal spree sends message to Euro rivals: Kane
-
Spy chief Clayton, the Trump loyalist tech bosses trust on AI
-
Trump confirms national intelligence chief as new AI czar
-
UK's Glastonbury festival tickets sell out in 45 minutes
-
Up to 500 French schools to be totally or partly closed Monday: minister
-
Two dead in Catalonia due to torrential rains: Spanish officials
-
Sydney Roosters edge Knights in tense NRL grand final
-
Verstappen claims first win of year in chaotic Bahrain GP in Malaysia
-
Sabalenka out of China Open in third round, Medvedev into semis
-
Red Bull's Verstappen wins Bahrain Grand Prix in Malaysia
-
Ethiopia controls Tigray capital as regional rivals meet in Egypt
-
أليكس بودي وسفير جمهورية جنوب السودان غوم دومينيك ماتيوك يبحثان في برلين إمكانية إنشاء قنصلية فخرية في بوخارست
-
Ο ΑΛΕΞ ΜΠΟΝΤΙ ΚΑΙ Ο ΠΡΕΣΒΗΣ ΤΗΣ ΔΗΜΟΚΡΑΤΙΑΣ ΤΟΥ ΝΟΤΙΟΥ ΣΟΥΔΑΝ ΓΚΟΥΜ ΝΤΟΜΙΝΙΚ ΜΑΤΙΟΚ ΣΥΖΗΤΟΥΝ ΣΤΟ ΒΕΡΟΛΙΝΟ ΤΟ ΕΝΔΕΧΟΜΕΝΟ ΙΔΡΥΣΗΣ ΕΠΙΤΙΜΟΥ ΠΡΟΞΕΝΕΙΟΥ ΣΤΟ ΒΟΥΚΟΥΡΕΣΤΙ
-
ALEX BODI OCH REPUBLIKEN SYDSUDANS AMBASSADÖR GUM DOMINIC MATIOK DISKUTERAR I BERLIN MÖJLIGHETEN ATT INRÄTTA ETT HONORÄRKONSULAT I BUKAREST
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
P.Martin--AMWN